MedPath

The Randomized Controlled Trial Evaluating Utility of Catheter Ablation Us ing ExTRa mapping for Atrial Fibrillation (ROTATE srudy)

Not Applicable
Recruiting
Conditions
Atrial fibrillation
Registration Number
JPRN-UMIN000043393
Lead Sponsor
Kyoto University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Patients whose atrial fibrillation was restored after only pulmonay veins isolation Patients who received ablation procedure or MAZE procedure for for atrial fibrillation before enrollment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Atrial arrhythmia recurrence beyond 90 days after catheter ablation for atrial fibrillation
Secondary Outcome Measures
NameTimeMethod
Atrial fibrillation termination rate Atrial fibrillation-free survival, atrial tachycardia-free survival Procedure detail (procedure time, ablation number, ablation region) Adverse events Atrial arrhythmia recurrence beyond 90 days after repeat procedures The difference of results compared between the different ExTRa-guide ablation in combined data with CONTROL-AF study
© Copyright 2025. All Rights Reserved by MedPath